Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Aug 3.
Published in final edited form as: J Am Chem Soc. 2017 Jun 2;139(23):7701–7704. doi: 10.1021/jacs.7b03266

Remarkably Stereospecific Utilization of ATP α,β-Halomethylene Analogues by Protein Kinases

Feng Ni †,‡,#, Alvin Kung †,‡,#, Yankun Duan ‖,§,#, Vivek Shah , Carolina D Amador , Ming Guo , Xuegong Fan , Lin Chen †,§, Yongheng Chen ⊥,*, Charles E McKenna †,*, Chao Zhang †,‡,*
PMCID: PMC5541949  NIHMSID: NIHMS882396  PMID: 28535041

Abstract

ATP analogues containing a CXY group in place of the α,β-bridging oxygen atom are powerful chemical probes for studying ATP-dependent enzymes. A limitation of such probes has been that conventional synthetic methods generate a mixture of diastereomers when the bridging carbon substitution is nonequivalent (X ≠ Y). We report here a novel method based on derivatization of a bisphosphonate precursor with a D-phenylglycine chiral auxiliary that enables preparation of the individual diastereomers of α,β-CHF-ATP and α,β-CHCl-ATP, which differ only in the configuration at the CHX carbon. When tested on a dozen divergent protein kinases, these individual diastereomers exhibit remarkable diastereospecificity (up to over 1000-fold) in utilization by the enzymes. This high selectivity can be exploited in an enzymatic approach to obtain the otherwise inaccessible diastereomers of α,β-CHBr-ATP. The crystal structure of a tyrosine kinase Src bound to α,β-CHX-ADP establishes the absolute configuration of the CHX carbon and helps clarify the origin of the remarkable diastereospecificity observed. We further synthesized the individual diastereomers of α,β-CHF-γ-thiol-ATP and demonstrated their utility in labeling a wide spectrum of kinase substrates. The novel ATP substrate analogues afforded by these two complementary strategies should have broad application in the study of the structure and function of ATP-dependent enzymes.


ATP is an essential nucleotide cofactor for numerous enzymes critical for life processes, ranging from protein kinases and ATPases to nitrogenases.1,2 Chemical modification of ATP has been a widely employed approach to probe the active-site structures, enzymatic mechanisms and cellular functions of ATP-dependent enzymes.3,4 Replacement of the α, β-bridging oxygen with a methylene linker (CH2) facilitates protein crystallization5 and, in general, nucleotides with appropriately substituted bridging methylenes (CXY) are useful mechanistic probes69 or for other purposes such as in vivo expansion of the genetic alphabet.10 A limitation of such probes has been that conventional synthetic methods generate a mixture of diastereomers when the bridging carbon substitution is nonequivalent (X ≠ Y).1113 Recently, the individual stereoisomers of β, γ-CXY-dGTP (X/Y = hydrogen or halogen) were successfully prepared14 and exhibited 5–10-fold stereo-specificity in DNA polymerase β catalysis.15 Among other CXY nucleotide analogues, the α, β-CHN3 dATP and β, γ-CHF ATP diastereomers, which are inhibitors for pol β and Src kinase, respectively, have been obtained as separate compounds.6,16 However, the synthesis of individual stereoisomers of α, β-CHF-ATP and its halo homologues, which are substrate mimics of ATP for kinases, has remained an unmet challenge.8

We report here a synthetic strategy to prepare the first examples of individual α, β-CHX-ATP diastereomers. The method involves three steps (Scheme 1): (i) conversion of the precursor α, β-CHX-ADP diastereomeric mixture 1 to a D-phenylglycine phosphoramidate derivative 2; (ii) separation of the two diastereomers of 2 using preparative nonchiral reverse phase (RP) HPLC; and (iii) treatment of the isolated individual diastereomers of 2 with 85% H3PO4 to afford both individual triphosphate (3) and diphosphate (4) nucleotide analogues in a single reaction. In this synthesis, D-phenylglycine serves a dual role as both a chiral auxiliary ligand and to activate the bisphosphonate moiety for subsequent phosphorylation. H3PO4 also plays a dual role, providing an acidic medium to remove the protecting isopropylidene group and serving as the phosphate donor. The use of these reagents in dual roles enabled a concise and efficient chemical route to the α, β-CHX-ATP diastereomers that is 5 steps shorter than the route previously developed for the β, γ-CHX-dGTP stereoisomers.14 The two isomers of 3 synthesized by the present method are designated as 3x-1 and 3x-2 based on the elution order of their corresponding phosphoramidate precursors 2x-1/2x-2 (x = a or b) under RP-HPLC (Figures S1 and S2). Their α-phosphorusnuclei show detectably different 31P NMR chemical shifts (Δδ ∼ 0.13 and 0.19 ppm for 3a-1/2 and 3b-1/2, respectively) (Figures S3 and S4).17

Scheme 1.

Scheme 1

Synthesis of Individual α, β-CHX (X = F, Cl) ATP Diastereomers

The pure diastereomers of α, β-CHX-ATP (3a-1, 3a-2, 3b-1 and 3b-2) were first evaluated in comparison to ATP, α, β-CH2-ATP and α, β-CF2-ATP for their utilization by a prototypical tyrosine kinase Src, which is frequently overexpressed in cancers.18 The kinetic parameters (Table 1), obtained using the Omnia kinase assay, show that α, β-CF2-ATP was utilized by Src with similar efficiency to ATP whereas α, β-CH2-ATP was an extremely poor substrate. An end-point assay based on 1H NMR revealed the same trend (Figure S5). The specificity constants (kcat/KM) of these two nucleotides differ by >1000-fold suggesting that, for Src recognition, the CF2 group is a much better mimic of the oxygen atom in ATP than CH2. 3a-2 has a comparable KM to ATP whereas its kcat is approximately 2-fold smaller. In contrast, 3a-1’s KM is over 30-fold greater than that of the active diastereomer whereas its kcat is over 50-fold smaller. Interestingly, the two α, β-CHF-ATP diastereomers appear to mimic α, β-CH2-ATP and α, β-CF2-ATP rather than each other in terms of utilization by Src. Given that CHF phosphonates have long been considered to be isoacidic mimics of biological phosphates,19 our observation that the specificity constant of the inert diastereomer 3a-1 is at least 1000-fold lower than 3a-2, in agreement with the high selectivity observed from NMR (31P of ATP and ADP analogues, Figure S6) and Western-blot analysis (phosphotyrosine, Figure S7). The α, β-CHCl-ATP isomers (3b-1 and 3b-2) were utilized by the Src kinase with even higher diastereoselectivity than that of α, β-CHF-ATP, though their kcat values are substantially smaller than those of α, β-CHF-ATP (Table 1 and Figure S8). The lower KM value of 3b-2 than that of 3a-2 may reflect a higher binding affinity of the chlorine analog to the Src kinase than the fluorine one as the same trend was observed with Ki values of 4b-2 and 4a-2 (Table S1). This striking selectivity greatly exceeds that observed with DNA polymerase β15 in utilizing substrates modified at β, γ-CXY bridge.

Table 1.

Kinetic Parameters of ATP Analogues as Src Substrates

ATP analogue KM (mM) kcat (min−1) Stereospecificity (kcat/KM)S/(kcat/KM)R




ATP 0.085 ± 0.010 167 ± 56 n.a.
α, β-CH2-ATP 1.6 ± 0.47 0.17 ± 0.025
α, β-CF2-ATP 0.034 ± 0.004 84 ± 1.3
3a-1 (R)-CHF 1.6 ± 0.3 1.5 ± 0.6 1.5 × 103
3a-2 (S)-CHF 0.042 ± 0.0053 59 ± 21
3b-1 (R)-CHCl 5.1 ± 0.52 0.22 ± 0.0018 1.8 × 103
3b-2 (S)-CHCl 0.0087 ± 0.0020 0.69 ± 0.10

To assign absolute stereoconfiguration at the CHF carbon as a basis to understand the diastereoselective utilization of α, β-CHF-ATP by Src, we cocrystallized Src with 3a-2, 3b-2, 4a-2 and 4b-2, the enzymatic substrates and products of the better substrate isomers (solved to 2.0–2.4 Å resolutions, Table S2). Given the low observable electron density for the γ-phosphoryl group in the 3b-2/Src structure and the virtually identical complex structures for 3b-2 and 4b-2, we suspect that 3b-2 underwent hydrolysis and lost its γ-phosphoryl group during the course of crystallization. Regardless, the well-defined electron density map allowed us to determine unambiguously the stereoconfiguration of the CHX carbon in 4a-2 and 4b-2 as R (Figure 1A,B). Therefore, the corresponding triphosphate 3a-2 and 3b-2 has the S configuration at the CHX carbon. Interestingly, the conformations of the kinase glycine-rich loop (P loop) and the nucleotide cofactor in the 4a-2/Src structure resemble the previously described active state of Src whereas those in the 4b-2/Src structure are close to the inactive state of Src (Figure 1C).20 This may account for the lower kcat for 3b-1 than that for 3a-1. Moreover, the fluorine atom in 4a-2 is only 3.4 Å away from the ε-nitrogen of the catalytic lysine (K295) in Src, suggesting the presence of a favorable interaction through an electrostatic interaction with the polar F atom.12 In contrast, the chlorine atom in the 4b-2 occupies a small hydrophobic pocket formed between the β1 and β2 strands, which may account for the lower KM of 3b-2 than that of 3a-2. When the opposite diastereomer (4a-1 or 4b-1) is modeled into the Src active site with the same conformation as 4a-2 or 4b-2, the resulting complexes not only lose the halogen-mediated interactions but also have an unfavorable steric overlap between the halogen atom and the main chain amide of Q275/G276 within the glycine-rich loop (P loop) (Figure S9), highlighting the importance of the intimate interaction between ATP and the P loop in kinase catalysis. With its larger Cl atom, 4b-1 is predicted to have a greater steric clash than the corresponding fluorine analog, thus accounting at least in part for the higher diastereoselectivity for 3b-1/2.

Figure 1.

Figure 1

Co-crystal structures of Src and ATP analogs. (A) Co-crystal structure of Src/4a-2 establishes the absolute configuration of the nucleotide and reveals its interaction with the K295 of Src. Stick model of α, β-CHF-ADP overlaid with |2FoFc| electron density (blue mesh, contoured at 1σ). (B) Co-crystal structure of Src/4b-2. (C) Structural overlay reveals that the bisphosphonate moiety of (R)-α, β-CHF-ADP (green) assumes a similar conformation to that of γ-thiol-ATP (cyan) bound to Src (3DQW). (D) Overlay of the α, β-CHX nucleotide bound Src structures with the previously solved active (3DQW) and inactive (2SRC) Src structures reveal different conformations of the glycine-rich loop.

We attempted to obtain the individual α, β-CHBr-ATP diastereomers, motivated by the Br atom’s well-known utility in producing phase information for protein cocrystals21 and its ability to form stronger halogen bonds than F and Cl.22 Our auxiliary strategy failed to make available individual α, β-CHBr-ATP diastereomers because the CHBr phosphoramidate precursors could not be well resolved by RP-HPLC. However, the observed high stereoselectivity of Src toward 3a and 3b suggested an alternative method to produce individual α, β-CHX-ATP diastereomers. Incubation of a α, β-CHBr-ATP diastereomer mixture11 with the Src kinase, Src-tide, and a tyrosine phosphatase YopH affords a catalytic cycle for phosphorylation of Src-tide (Figure 2). Using this enzymatic system, we succeeded in converting only one diastereomer of α, β-CHBr-ATP into the diphosphate form, which could be readily separated from the remaining triphosphate diastereomer by anion-exchange HPLC (Figure S10). The same method also succeeded in the enzymatic resolution of a mixture of α, β-CHCl-ATP diastereomers (Figure S11).

Figure 2.

Figure 2

Enzymatic approach to resolve a mixture of α, β-CHX-ATP diastereomers.

To test the generality of diastereoselective utilization of α, β-CHX-ATP by kinases, we measured the kinetic parameters of 3a-1 and 3a-2 along with ATP for a panel of 12 divergent kinases using an established microfluidic assay based on mobility shift of peptide substrates upon phosphorylation.23 The KM and kcat values could be calculated for both 3a-1 and 3a-2 for nine out of the twelve kinases, which display stereospecificity constants ranging from 8 to 174 (Table S3). The different stereospecificity determined for Src kinase using the fluorescence-based and mobility shift-based assays may be due to the differences between the two assays and the Src proteins used. The kinetic parameters could be derived for 3a-2 but not 3a-1 (activity below detection limit) for three other kinases, which again show preference for the same diastereomer. These results suggest that high stereospecificity for α, β-CHF-ATP seems to be common to many protein kinases.

To examine further the scope of this selectivity, we tested the ability of α, β-CHF-ATPs to serve as the phosphoryl donor in the whole proteome in HEK293 cell lysates, taking advantage of a chemical-immunological method for detecting thiophosphorylation developed by Shokat.24 The previously unavailable individual diastereomers of α, β-CHF-γ-thiol-ATP were synthesized by treating the separated diastereomers 2a with thiophosphate followed by deprotection with HCl at −20 °C (Scheme 1). (S)-α, β-CHF-γ-S-ATP produced intense labeling of numerous proteins throughout the lane, whereas the R diastereomer caused no visible labeling of any bands (Figure 3), demonstrating that protein kinases generally exhibit high selectivity for (S)-α, β-CHF-γ-S-ATP in phosphorylating a wide spectrum of substrates. Although it produced a labeling pattern that is similar overall to that of γ-S-ATP, (S)-α, β-CHF-γ-S-ATP labeled a prominent band of ∼33 kDa not labeled by γ-S-ATP (Figure 3), suggesting that certain cellular kinases utilize (S)-α, β-CHF-γ-S-ATP more efficiently than γ-S-ATP. Identification of such kinases and their substrates using our probes will provide valuable new insight for understanding biological phosphorylation mechanisms.

Figure 3.

Figure 3

Utilization of γ-S-ATP, (R)-α, β-CHF-γ-S-ATP and (S)-α, β-CHF-γ-S-ATP by various kinases to phosphorylate substrate proteins in cell lysates. All γ-S nucleotides were used at 0.25 mM, and thiolphosphorylation was detected using a monoclonal antibody.

In conclusion, we describe the first preparation of the individual diastereomers of α, β-CHX-ATP where X = F or Cl. Remarkable stereospecificity (>1000-fold) was observed in the utilization of these α, β-CHX-ATP diastereomers by Src kinase. Crystal structure analysis established the absolute configuration of the CHF and CHCl nucleotide analogues and reveals a potential electrostatic interaction between the fluorine atom in (R)-α, β-CHF-ADP and the ε-amino group of the catalytic lysine. Finally, we demonstrate that the observed selectivity is general for a wide range of eukaryotic protein kinases. Our results raise the interesting possibility that an engineered kinase capable of accepting (R)-α, β-CHX-ATP (the inert isomer) with high efficiency can be used for kinase substrate identification as in the bump−hole approach.25 Beyond providing new mechanistic insights on one of the most centrally important enzymes utilizing ATP, individual α, β-CHX-ATP stereoisomers should have wide application in the study of numerous additional ATP-dependent enzymes.

Supplementary Material

Supporting Info

Acknowledgments

We thank staff members of beamline BL17U at the Shanghai Synchrotron Radiation Facility for their assistance in data collection, and Dr. B.A. Kashemirov for his expert advice in mass spectrometry analyses. This work was supported in part by NSF (CHE-1455306 to C.Z.), NIH (1U19 CA177547 to C.E.M.) and NSFC (81372904 and 81570537 to Y.C.).

Footnotes

Supporting Information

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/jacs.7b03266.

Experimental details and characterization data (PDF)

ORCID

Chao Zhang: 0000-0003-0251-8156

Notes

The authors declare no competing financial interest.

References

  • 1.Cleland WW, Hengge AC. Chem Rev. 2006;106:3252. doi: 10.1021/cr050287o. [DOI] [PubMed] [Google Scholar]
  • 2.Hoffman BM, Lukoyanov D, Yang ZY, Dean DR, Seefeldt LC. Chem Rev. 2014;114:4041. doi: 10.1021/cr400641x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Elphick LM, Lee SE, Gouverneur V, Mann DJ. ACS Chem Biol. 2007;2:299. doi: 10.1021/cb700027u. [DOI] [PubMed] [Google Scholar]
  • 4.Korhonen HJ, Conway LP, Hodgson DRW. Curr Opin Chem Biol. 2014;21:63. doi: 10.1016/j.cbpa.2014.05.001. [DOI] [PubMed] [Google Scholar]
  • 5.Pedersen LC, Benning MM, Holden HM. Biochemistry. 1995;34:13305. doi: 10.1021/bi00041a005. [DOI] [PubMed] [Google Scholar]
  • 6.Hwang CS, Kung A, Kashemirov BA, Zhang C, McKenna CE. Org Lett. 2015;17:1624. doi: 10.1021/ol503765n. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kadina AP, Kashemirov BA, Oertell K, Batra VK, Wilson SH, Goodman MF, McKenna CE. Org Lett. 2015;17:2586. doi: 10.1021/acs.orglett.5b00799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chamberlain BT, Batra VK, Beard WA, Kadina AP, Shock DD, Kashemirov BA, McKenna CE, Goodman MF, Wilson SH. ChemBioChem. 2012;13:528. doi: 10.1002/cbic.201100738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hwang CS, Xu L, Wang W, Ulrich S, Zhang L, Chong J, Shin JH, Huang XH, Kool ET, McKenna CE, Wang D. Nucleic Acids Res. 2016;44:3820. doi: 10.1093/nar/gkw220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Feldman AW, Dien VT, Romesberg FE. J Am Chem Soc. 2017;139:2464. doi: 10.1021/jacs.6b12731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Upton TG, Kashemirov BA, McKenna CE, Goodman MF, Prakash GK, Kultyshev R, Batra VK, Shock DD, Pedersen LC, Beard WA, Wilson SH. Org Lett. 2009;11:1883. doi: 10.1021/ol701755k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.McKenna CE, Kashemirov BA, Upton TG, Batra VK, Goodman MF, Pedersen LC, Beard WA, Wilson SH. J Am Chem Soc. 2007;129:15412. doi: 10.1021/ja072127v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Batra VK, Pedersen LC, Beard WA, Wilson SH, Kashemirov BA, Upton TG, Goodman MF, McKenna CE. J Am Chem Soc. 2010;132:7617. doi: 10.1021/ja909370k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wu Y, Zakharova VM, Kashemirov BA, Goodman MF, Batra VK, Wilson SH, McKenna CE. J Am Chem Soc. 2012;134:8734. doi: 10.1021/ja300218x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Oertell K, Wu Y, Zakharova VM, Kashemirov BA, Shock DD, Beard WA, Wilson SH, McKenna CE, Goodman MF. Biochemistry. 2012;51:8491. doi: 10.1021/bi3010335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chamberlain BT, Upton TG, Kashemirov BA, McKenna CE. J Org Chem. 2011;76:5132. doi: 10.1021/jo200045a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.For the (R)- and (S)-α,β-CHFATP diastereomers, the 19F Δδ is nearly 1 order of magnitude larger (0.45 ppm) than previously reported for β,γ-CHF nucleotides12 (∼0.05 ppm), with fully resolved multiplets at 470 MHz, providing a convenient alternative NMR analysis to monitor differential turnover kinetics.
  • 18.Irby RB, Yeatman TJ. Oncogene. 2000;19:5636. doi: 10.1038/sj.onc.1203912. [DOI] [PubMed] [Google Scholar]
  • 19.Berkowitz DB, Bose MJ. Fluorine Chem. 2001;112:13. [Google Scholar]
  • 20.Xu WQ, Doshi A, Lei M, Eck MJ, Harrison SC. Mol Cell. 1999;3:629. doi: 10.1016/s1097-2765(00)80356-1. [DOI] [PubMed] [Google Scholar]
  • 21.Pike ACW, Garman EF, Krojer T, von Delft F, Carpenter EP. Acta Crystallogr D. 2016;72:303. doi: 10.1107/S2059798316000401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Auffinger P, Hays FA, Westhof E, Ho PS. Proc Natl Acad Sci USA. 2004;101:16789. doi: 10.1073/pnas.0407607101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Elkins JM, Fedele V, Szklarz M, Abdul Azeez KR, Salah E, Mikolajczyk J, Romanov S, Sepetov N, Huang XP, Roth BL, Al Haj Zen A, Fourches D, Muratov E, Tropsha A, Morris J, Teicher BA, Kunkel M, Polley E, Lackey KE, Atkinson FL, Overington JP, Bamborough P, Muller S, Price DJ, Willson TM, Drewry DH, Knapp S, Zuercher WJ. Nat Biotechnol. 2016;34:95. doi: 10.1038/nbt.3374. [DOI] [PubMed] [Google Scholar]
  • 24.Allen JJ, Lazerwith SE, Shokat KM. J Am Chem Soc. 2005;127:5288. doi: 10.1021/ja050727t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Shah K, Liu Y, Deirmengian C, Shokat KM. Proc Natl Acad Sci USA. 1997;94:3565. doi: 10.1073/pnas.94.8.3565. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Info

RESOURCES